Our Expert in India
No results available
This is general guidance, seek tailored legal advice before acting on any point below.
Cross-border M&A India transactions live or die on regulatory timing, and in 2026 a common cause of a missed closing is not price or diligence but the overlapping approval stack of FDI clearance, competition filings, foreign-exchange compliance and sectoral consents. In-house counsel, private equity sponsors and deal partners increasingly report that delays accumulate when approvals are treated as an afterthought rather than a pre-signing workstream. This article gives you a partner-grade, decision-ready playbook: a quick checklist, a regulator-by-regulator timing matrix, a pre-signing versus post-closing decision table, annotated sample clauses, timeline templates and an escalation ladder. Read it as an execution runbook, not a legal treatise, every section tells you what to do and when.
For the full practice context, see our Cross‑Border M&A, India practice area page.
The economics of a deal assume a closing date. When regulatory delays in M&A push that date, financing commitments lapse, material adverse change windows widen, management teams drift, and sellers lose patience. In India the risk is amplified because approvals rarely run in a single lane: a control acquisition in a regulated sector can simultaneously trigger DPIIT review (for government-route sectors), a Competition Commission of India (CCI) notification, RBI/FEMA reporting, and a sectoral consent, each with its own documentation, its own clock and its own officials.
The practitioner trend in 2026 is unambiguous: active, early regulator engagement and pre-signing structuring beat reactive firefighting every time. The deals that close on schedule are those where counsel mapped every approval trigger before the term sheet was signed, prepared complete filing packages, and allocated delay risk contractually. The deals that slip are those where someone assumed an “automatic route” filing was a formality. This playbook is built to help you avoid the second outcome.
Use this as your India M&A checklist from the first call. It is organised by phase so your deal team knows what must be true before signing, before closing, and after.
Keep a one-page checklist and clause pack on the deal shared drive from day one.
This is the centrepiece. Each regulator below has a different filing trigger, a different clock and a different failure mode. Treat them as parallel workstreams, not a queue.
Foreign investment in India runs on two routes: the automatic route, where no prior government approval is needed, and the government route, where prior approval is required for specified sectors and above specified caps. The policy framework is set out in the Consolidated FDI Policy maintained by the Department for Promotion of Industry and Internal Trade (DPIIT) and implemented through the Foreign Exchange Management (Non-debt Instruments) Rules, 2019. The practical trap is assuming automatic treatment without confirming the sectoral entry conditions and performance conditions that attach to it. Prepare, at a minimum, a consolidated ownership chart, the downstream investment structure, beneficial-ownership disclosures and the sectoral cap analysis.
Government-route applications are filed and processed through the Foreign Investment Facilitation Portal (and routed to the relevant administrative ministry). Administrative processing times vary with complexity and can run into several weeks or months. Common causes of delay are incomplete disclosures, unclear beneficial ownership, and mid-process sectoral policy changes. Note that, under Press Note 3 (2020), investments from entities of countries sharing a land border with India (or where the beneficial owner is situated in or is a citizen of such a country) require prior government approval regardless of sector. Mitigate by confirming caps immediately, preparing the application package before signing, and engaging early.
If approval cannot be secured pre-signing, make it a pre-closing condition precedent, tie a long-stop to it, and build an escrow for remediation obligations.
A notification to the Competition Commission of India is triggered when the transaction qualifies as a “combination” by crossing the prescribed asset or turnover thresholds under the Competition Act, 2002 and the Combination Regulations, unless an exemption applies (for example, certain small-target/de minimis exemptions). Following the amendments introduced by the Competition (Amendment) Act, 2023, a “deal value threshold” also applies to transactions above a prescribed value with substantial business operations in India. Clearance timelines are prescribed by statute and regulation; the Commission must form a prima facie view within a short statutory window, and combinations raising competition concerns proceed to an extended in-depth review that can add months.
The most common causes of delay are disputes over market definition, incomplete market-share data and concentration concerns that invite remedies. A notifiable combination cannot be given effect until approved (or deemed approved), and failure to notify risks penalties. Practical mitigation: run an early market screen, assemble the competition notice package in parallel with legal diligence, and involve competition counsel from the borderline-threshold stage onward. Where filing cannot precede closing, plan for behavioural or structural remedies, hold back consideration, and price in a break fee if CCI risk is material.
The Reserve Bank of India, together with the Government, governs the foreign-exchange dimension of cross-border M&A India through FEMA, covering inbound investment reporting, Overseas Investment (OI/ODI) for outbound structures under the Foreign Exchange Management (Overseas Investment) Rules and Regulations, 2022, and external commercial borrowings used to fund deals. Many transactions proceed under automatic routes but still carry mandatory reporting (for example, Form FC-GPR for issue of shares and Form FC-TRS for transfers between residents and non-residents, filed through the RBI’s FIRMS portal, and Form FLA annual reporting). Others require specific RBI or Government engagement. Processing and compliance times vary with complexity and KYC completeness. The usual delay drivers are foreign-exchange compliance gaps, missed reporting deadlines and complex ODI structures.
Non-compliance may be addressed through the compounding process but can attract penalties and, critically, can block repatriation and financing. Scope FEMA/OI applicability early, bring tax and forex counsel in at structuring, prepare KYC and filing documents, and engage the AD bank at the outset. Where reporting cannot precede closing, make repatriation-related steps a condition precedent and hold consideration in escrow until reporting is complete.
Where the target is listed, an acquisition that crosses the substantial-acquisition or control thresholds triggers mandatory open-offer and disclosure obligations under the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, which impose fixed timelines once triggered. In broad terms, an acquisition taking the acquirer’s holding to 25% or more, or further acquisition beyond prescribed creeping-acquisition limits, or an acquisition of control, can trigger an open offer, but the precise thresholds and exemptions should be confirmed against the current Regulations for the specific facts. The failure modes are miscalculating creeping-acquisition thresholds and disclosure lapses, both of which carry penalties and remedial obligations.
Model the acquisition against the thresholds early, plan cash and financing for a potential open offer, and coordinate the public-disclosure plan with the signing timetable. If an open offer is in play, make open-offer funding a pre-closing requirement, allocate costs by covenant, and escrow the open-offer funding.
Regulated sectors add a further consent layer tied to the change of control of a licensed entity. Telecom licence transfers require Department of Telecommunications (DoT) consent; insurance acquisitions require Insurance Regulatory and Development Authority of India (IRDAI) approval, which involves fitness-and-propriety assessment; and pharmaceutical and medical-device entities may interact with the Central Drugs Standard Control Organisation (CDSCO) and state licensing authorities. Timelines are sector-dependent and can run into weeks or months. The common objections concern licence-transfer conditions, fitness-and-propriety checks on acquirers, and sector-specific policy interventions. Non-consent can void the transfer or restrict operations. Identify every sectoral licence early, confirm transferability and timeline in writing, pre-meet the regulator where practicable, and prepare fitness-and-propriety packages in advance.
Make the sectoral consent a closing condition, include walkaway rights, and tailor an escrow for any remedial undertakings.
Table: regulator-by-regulator filing triggers, timing and recommended deal terms for cross-border M&A India. Timelines are indicative only and must be confirmed against current rules for the specific transaction.
| Approval / Decision | Filing trigger | Timing (indicative) | Typical causes of delay | Liability / enforceability risk | Pre-signing recommended action | Suggested deal term if pre-filing not possible |
|---|---|---|---|---|---|---|
| DPIIT / FDI (government route) | Acquisition in a sector requiring prior government approval, or where Press Note 3 applies | Varies by sector and complexity; weeks to months | Incomplete disclosures, beneficial-ownership issues, sectoral policy changes | Transaction may be voidable or penalised; remediation obligations | Confirm caps; engage early; prepare ownership chart and downstream structure | Pre-closing condition; long-stop tied to approval; escrow; reverse break fee |
| CCI (merger control) | Combination asset/turnover (or deal-value) thresholds met and no exemption applies | Statutory review windows; extended review can add months | Market-definition disputes, incomplete data, concentration concerns | Penalty and standstill/unwinding risk; conditional approvals with remedies | Early market screen; assemble notice package; involve competition counsel | Holdback/undertakings; plan for remedies; break fee if risk material |
| RBI / FEMA (OI/ODI, inbound, ECB) | Cross-border payments, upstream investments, ODI structures, reporting obligations | Weeks to months depending on complexity and KYC | Forex compliance gaps, missed reporting, complex ODI structures | FEMA penalties/compounding; blocked repatriation/financing | Early FEMA/OI scoping; prep KYC and filings; engage AD bank | Condition precedent for repatriation; escrow until reporting complete |
| SEBI / SAST (open offer) | Crossing substantial-acquisition/creeping thresholds or acquiring control | Fixed timelines once triggered | Miscalculated creeping thresholds; disclosure lapses | Mandatory open offer; fines; remedial obligations | Model acquisition against thresholds; plan open-offer financing | Open-offer funding pre-committed; cost covenants; escrow for funding |
| Sectoral (DoT, IRDAI, CDSCO) | Transfer / change of control of a licensed entity | Sector-dependent: weeks to months | Licence-transfer conditions; fitness-and-propriety checks; policy interventions | Transfer may be void or operations restricted | Identify licence early; confirm transferability; pre-meet regulator | Regulatory consent as closing condition; walkaway rights; tailored escrow |
Most delay risk is designed out, or designed in, at the structuring stage. Spend the time here.
The right structure is the one that minimises mandatory pre-closing approvals while preserving tax and commercial outcomes. Author’s note, seek jurisdictional counsel: structure choice interacts with tax and FEMA rules and must be validated for the specific deal.
Run pre-signing due diligence India work with the approval stack in mind, not as a generic exercise. Prioritise: foreign-investment cap compliance in the target’s history; the status, expiry and transferability of every sectoral licence; historic FEMA reporting completeness; prior CCI filings and any outstanding undertakings; and the target’s control structure for SAST purposes. These are the data points regulators will ask about, assembling them early materially reduces your post-signing response time.
When you cannot secure an approval before signing, contract allocation is your protection. The annotated snippets below show the mechanics. Author’s note, seek jurisdictional counsel: these are drafting illustrations, not off-the-shelf clauses.
Sample: “If the Regulatory Conditions have not been satisfied or waived by the Long-Stop Date, either party may terminate this Agreement by written notice. The Long-Stop Date shall be automatically extended by [60] days where an approval application remains pending and the parties are using reasonable endeavours to progress it.” Drafting note: set the base long-stop to the longest realistic approval timeline from the matrix above, and build one automatic extension so a near-complete approval does not collapse the deal. Avoid open-ended extensions that strand the seller.
Sample: “If this Agreement terminates because a Regulatory Condition attributable to the Buyer’s status or group structure is not satisfied by the Long-Stop Date, the Buyer shall pay the Seller a reverse break fee of [amount] as the Seller’s sole financial remedy.” Drafting note: tie the trigger precisely to buyer-side regulatory risk (for example, the buyer’s own FDI eligibility or competition footprint). Negotiate the quantum against the seller’s realistic cost of a failed process, and confirm enforceability under applicable law.
Sample: “A sum equal to [amount] shall be held in escrow and released to the Seller only upon delivery of evidence that (i) the RBI/FEMA reporting has been filed and acknowledged and (ii) the Sectoral Consent has been obtained unconditionally; failing which the escrow shall be applied to remediation costs.” Drafting note: link each tranche to a specific, evidenced regulatory milestone so release is objective and disputes are minimised.
Sample: “Completion is conditional on each Regulatory Approval listed in Schedule [X] being obtained in a form reasonably satisfactory to the Buyer and without any condition that would be materially adverse to the Target’s business.” Drafting note: the “materially adverse condition” qualifier protects the buyer against burdensome remedies imposed by CCI or a sectoral regulator, define it tightly to avoid disputes over what counts as material.
Translate the matrix into a critical-path schedule. Two common scenarios illustrate the discipline required. The week ranges below are illustrative and should be calibrated to the specific deal.
Scenario A, FDI-only (automatic route), straightforward target:
Scenario B, CCI + RBI + sectoral consent, regulated target (critical path = CCI/sectoral):
Recommended internal disciplines: counsel completes each notice pack promptly after signing; the deal team responds to any regulator query without delay; and the acquirer confirms financing availability against the latest long-stop at each weekly checkpoint.
Escalation is a managed sequence, not a panic response. Start with persistent, documented engagement with the case officer and, where a filing stalls despite complete submissions, a representation to the relevant secretariat or a request for a senior-level meeting on policy-sensitive matters. Judicial and tribunal routes, a writ petition against unreasonable regulatory inaction, appeals to the National Company Law Appellate Tribunal (NCLAT) from CCI orders, or relief before the National Company Law Tribunal (NCLT) in change-of-control, scheme-of-arrangement or restructuring matters, sit at the top of the ladder. Weigh each rung against cost, duration and reputational exposure: litigation against a regulator you will deal with again carries lasting relationship cost, and public proceedings can harm deal confidence.
Escalate deliberately, with the commercial trade-off documented for the board.
| Choose pre-signing / pre-closing filing when… | Choose post-closing conditionality when… |
|---|---|
| The approval is mandatory and failure creates structural invalidity, significant penalties or operational prohibition (sectoral licence transfers, mandatory CCI filings in high-concentration deals, government-route FDI sectors). | The approval is not mandatory pre-closing under statute, thresholds are borderline, and commercial priority is deal certainty (e.g. seller wants to close for tax reasons). |
| The regulator routinely imposes structural remedies that cannot be cured post-closing by simple undertakings. | The buyer holds strong contractual protections, escrow, reverse break fee, clear remediation mechanics, and accepts the cost of underwriting potential remedies. |
| The buyer lacks appetite to underwrite substantial post-closing risk or remediation costs. | A fast closing delivers strategic value that outweighs delay risk, with financing and indemnity comfort in place. |
Rule of thumb: if statutory non-compliance can cause retrospective invalidation or operational prohibition, push for pre-closing filing. If the main consequence is a penalty or enforcement with remediable remedies, consider post-closing with robust contractual protection. Note that notifiable CCI combinations are subject to a standstill and generally cannot be consummated before clearance.
Avoiding regulatory delays in cross-border M&A India is a discipline, not a stroke of luck: map every approval trigger before signing, run the regulators as parallel workstreams against a critical-path timeline, decide deliberately which approvals to secure pre-closing versus manage post-closing, and allocate the residual risk with tight long-stops, reverse break fees and milestone-linked escrow. Teams that treat the approval stack as a day-one workstream close on schedule; teams that treat it as paperwork slip. For a deal-specific timetable consult the practitioners in our GLE lawyer directory, India, Cross‑Border M&A.
This is general guidance, seek tailored legal advice for your transaction.
This article was produced by Global Law Experts. For specialist advice on this topic, contact Shinoj Koshy at SK & Partners, a member of the Global Law Experts network.
posted 3 minutes ago
posted 23 minutes ago
posted 41 minutes ago
posted 46 minutes ago
posted 1 hour ago
posted 1 hour ago
posted 2 hours ago
posted 2 hours ago
posted 2 hours ago
posted 3 hours ago
posted 4 hours ago
posted 4 hours ago
No results available
Find the right Legal Expert for your business
Send welcome message